Transplantation-associated thrombotic microangiopathy (TA-TMA) is an infrequent but
devastating syndrome that occurs in allogeneic hematopoietic stem cell transplant …

Transplant-associated thrombotic microangiopathy (TA-TMA) is a multifactorial disorder
caused by systemic vascular endothelial injury that can be triggered by several mechanisms …

Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenging
diagnosis after hematopoietic stem cell transplantation. Although endothelial injury …

Each year in the US, more than 10 000 patients benefit from allogeneic haematopoietic stem
cell transplantation (HSCT), a modality that offers an excellent chance of eradicating …

Transplant-associated thrombotic microangiopathy (TA-TMA) refers to inflammatory and
thrombotic diseases of the microvasculature characterized by hemolytic anemia …

Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly
recognized complication of hematopoietic cell transplantation (HCT) associated with …

Background Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a multifactorial
disorder, which occurs as a result of treatment‐related endothelial injury and underlying …

Renewed interest has emerged in transplant‐associated thrombotic microangiopathy (TA‐
TMA) with novel prognostic, diagnostic, and treatment algorithms. We aimed to investigate …

Transplant-associated thrombotic microangiopathy (TA-TMA) after allogeneic hematopoietic
cell transplantation (HCT) has not been well characterized in large population studies with …

A syndrome of microangiopathic hemolytic anemia, renal dysfunction and neurological
abnormalities was first noted in bone marrow transplant recipients 22 years ago. Now known …